Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-26 @ 4:12 AM
Study NCT ID:
NCT00064727
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2003-07-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes
Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
030217
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None